Reportlinker finds all market research
reports published by official sources!
- Home
- Companies
- Companies in B
- Bioheart Inc.
- Bioheart Inc. - Company Report for Year 2011
Bioheart Inc. - Company Report for Year 2011
- This 9-page company report was published in December 2011.
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Talk to Sam
(866) 682 9815
Share
Biological Therapy Industry in the United States : Latest Downloads
Neostem Inc. - Company Report for Year 2012
- Company report
- September 2012
- 212 pages
... Pluripotent very small embryonic like (vsels) stem cells as a countermeasure to radiation threat" from the national institute of allergy and infectious diseases (niaid), a division of nih. This peer reviewed ...
Company Report: Biological Therapy for Year 2013
- Company report
- April 2013
- 38 pages
... Issues such as research intervention on human beings18; research on human embryos and human embryonic stem cells and non-human primates are automatically submitted for ethics review. To ensure ...
Company Report: Biological Therapy for Year 2012
- Company report
- December 2012
- 56 pages
- by Market Research Publisher
... Vivo therapeutics holdings corp., Investor presentation for lazard capital markets' 9th annual healthcare conference, slide 26, november 14, 2012. Geron stemcells, inc. Neuralstem , inc ...
Investor Presentation: Cell Therapy For Year ...
6 months agoCompany Report: Biological Therapy For Year 2 ...
8 months agoCompany Report: Biological Therapy For Year 2 ...
8 months agoCompany Report: Biological Therapy For Year 2 ...
9 months agoCompany Report: Biological Therapy For Year 2 ...
10 months agoCompany Report: Stem Cell For Year 2012
10 months agoCompany Report: Biological Therapy For Year 2 ...
11 months agoMore Reports:
Biological Therapy in China (5)
Company Reports
Biological Therapy Industry in the United States : Latest Reports
Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- April 2013
- by Global Data
Summary Bioheart, Inc. (Bioheart) is a biotechnology company. It focus on the treatment of cardiovascular related diseases. It discovers, develops and commercializes autologous cell therapies to treat ...
Bioheart, Inc. (Symbol:BHRT) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- April 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
Biological Therapy: Bioheart, Inc. (BHRT)
- $ 750
- Company report
- August 2012
- by Global Data
This report is a source for data, analysis and actionable intelligence on the Bioheart, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with ...
Reportlinker.com © Copyright 2013. All rights reserved.
